News

ESMO 2025: Blood test guides post-surgical immunotherapy for muscle-invasive bladder cancer

Survivors of high-risk neuroblastoma face substantial late effects of modern therapies

ESMO 2025: DNA shed by colon cancers may help personalise postsurgical treatment

Precision reprogramming: How AI tricks cancer’s toughest cells

Targeted immunotherapy combination offers hope to older adults with leukaemia

Combination therapy could expand treatment options for AML patients, extend survival

ESMO 2025: Research targets treatment resistance in neuroendocrine tumours

Disrupting cancer’s secret hubs: A new way to halt tumour growth

New insight in to role of immune system in colorectal cancer

Obesity-related cancer rising among both younger and older adults worldwide

ESMO 2025: Immunotherapy after surgery shows potential in preventing the spread of aggressive skin cancer

ESMO 2025: VT3989 continues to show promising early results in patients with advanced mesothelioma